
How Would the New Administration’s Nominations Impact Obesity Care?
The nomination of President Trump of Dr. Mehmet Oz to direct the services centers of Medicare and Medicaid (CMS) has generated buzz throughout the health industry. When it comes to obesity, Medicare and Medicaid treatment, they only cover Ozempic for diabetes treatment, not for out -of -label use such as